Skip to main content

Marijuana Use and Type 2 Diabetes Mellitus: a Review

Abstract

Marijuana is used by millions of people, with use likely to increase in the USA because of the trend towards increased decriminalization and legalization. Obesity and diabetes mellitus (DM) rates have increased dramatically in the USA over the past 30 years, with a recent estimate of 29 million individuals with DM. Because there is a plausible link between marijuana use and diabetes due to the known effects of cannabinoids on adipose tissue and glucose/insulin metabolism, it is important to study and understand how marijuana use is related to obesity and diabetes. This paper provides background on the human endocannabinoid system and studies of the association of marijuana use with body mass index/obesity, metabolic syndrome, prediabetes, and diabetes. The studies to date have shown that marijuana use is associated with either lower odds or no difference in the odds of diabetes than non-use.

This is a preview of subscription content, access via your institution.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Centers for Disease Control and Prevention. National Diabetes Statistics Report: Estimates of Diabetes and Its Burden in the United States, 2014. Atlanta, GA: U.S. Department of Health and Human Services: 2014.

  2. Center for Behavioral Health Statistics and Quality (CBHSQ). Behavioral Health Trends in the United States: Results from the 2014 National Survey on Drug Use and Health. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2015. HHS Publication No. SMA 15–4927, NSDUH Series H-50.

  3. http://www.governing.com/gov-data/state-marijuana-laws-map-medical-recreational.html, accessed 5/28/2016.

  4. http://www.drugpolicy.org/facts/drug-facts/marijuana/how-marijuana-consumed, accessed 5/28/2016

  5. Marijuana and Health: Report of a Study by a Committee of the Institute of Medicine, Division of Health Sciences Policy. National Academy Press. Washington, D.C.1982. http://www.nap.edu/read/18942/chapter/1

  6. Gaoni Y, Mechoulam R. Isolation, structure and partial synthesis of an active constituent of cannabis. J Am Chem Soc. 1964;86:1646–7.

    CAS  Article  Google Scholar 

  7. Devane WA, Dysarz FA, Johnson MR, et al. Determination and characterization of a cannabinoid receptor in the rat brain. Mol Pharmacol. 1988;34:605–13.

    CAS  PubMed  Google Scholar 

  8. Munro S, Thomas KL, Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature. 1993;365:61–5.

  9. Di Marzo V, Piscitelli F, Mechoulam R. Cannabinoids and endocannabinoids in metabolic disorders with focus on diabetes. Handb Exp Pharmacol. 2011;203:75–104. doi:10.1007/978-3-642-17214-4_4. Review.

    Article  Google Scholar 

  10. Lipina C, Rastedt W, Irving AJ, Hundal HS. New vistas for treatment of obesity and diabetes? Endocannabinoid signalling and metabolism in the modulation of energy balance. Bioessays. 2012;34(8):681–91. doi:10.1002/bies.201200031. Review.

    CAS  Article  PubMed  Google Scholar 

  11. Bermudez-Silva FJ, Cardinal P, Cota D. The role of the endocannabinoid system in the neuroendocrine regulation of energy balance. J Psychopharmacol. 2012;26(1):114–24. doi:10.1177/0269881111408458. Review.

    CAS  Article  PubMed  Google Scholar 

  12. Blüher M, Engeli S, Klöting N, Berndt J, Fasshauer M, Bátkai S, et al. Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity. Diabetes. 2006;55(11):3053–60.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Côté M, Matias I, Lemieux I, Petrosino S, Alméras N, Després JP, et al. Circulating endocannabinoid levels, abdominal adiposity and related cardiometabolic risk factors in obese men. Int J Obes (Lond). 2007;31(4):692–9.

    Google Scholar 

  14. Di Marzo V, Côté M, Matias I, Lemieux I, Arsenault BJ, Cartier A, et al. Changes in plasma endocannabinoid levels in viscerally obese men following a 1 year lifestyle modification programme and waist circumference reduction: associations with changes in metabolic risk factors. Diabetologia. 2009;52(2):213–7. doi:10.1007/s00125-008-1178-6.

    CAS  Article  PubMed  Google Scholar 

  15. Le Strat Y, Le Foll B. Obesity and cannabis use: results from 2 representative national surveys. Am J Epidemiol. 2011;174(8):929–33. doi:10.1093/aje/kwr200.

    Article  PubMed  Google Scholar 

  16. Smit E, Crespo CJ. Dietary intake and nutritional status of US adult marijuana users: results from the Third National Health and Nutrition Examination Survey. Public Health Nutr. 2001;4(3):781–6.

    CAS  Article  PubMed  Google Scholar 

  17. Hayatbakhsh MR, O’Callaghan MJ, Mamun AA, Williams GM, Clavarino A, Najman JM. Cannabis use and obesity and young adults. Am J Drug Alcohol Abuse. 2010;36(6):350–6. doi:10.3109/00952990.2010.500438.

    Article  PubMed  Google Scholar 

  18. Rodondi N, Pletcher MJ, Liu K, Hulley SB, Sidney S, Coronary Artery Risk Development in Young Adults (CARDIA) Study. Marijuana use, diet, body mass index, and cardiovascular risk factors (from the CARDIA study). Am J Cardiol. 2006;98(4):478–84.

    Article  PubMed  Google Scholar 

  19. Warren M, Frost-Pineda K, Gold M. Body mass index and marijuana use. J Addict Dis. 2005;24(3):95–100.

    Article  PubMed  Google Scholar 

  20. Mittleman MA, Lewis RA, Maclure M, Sherwood JB, Muller JE. Triggering myocardial infarction by marijuana. Circulation. 2001;103(23):2805–9.

    CAS  Article  PubMed  Google Scholar 

  21. Penner EA, Buettner H, Mittleman MA. The impact of marijuana use on glucose, insulin, and insulin resistance among US adults. Am J Med. 2013;126(7):583–9. doi:10.1016/j.amjmed.2013.03.002.

    CAS  Article  PubMed  Google Scholar 

  22. Yankey BN, Strasser S, Okosun IS. A cross-sectional analysis of the association between marijuana and cigarette smoking with metabolic syndrome among adults in the United States. Diabetes Metab Syndr. 2016;10(2 Suppl 1):S89–95. doi:10.1016/j.dsx.2016.03.001.

  23. Vidot DC, Prado G, Hlaing WM, Florez HJ, Arheart KL, Messiah SE. Metabolic Syndrome among marijuana users in the United States: an analysis of National Health and Nutrition Examination Survey data. Am J Med. 2016;129(2):173–9. doi:10.1016/j.amjmed.2015.10.019.

  24. Bancks MP, Pletcher MJ, Kertesz SG, Sidney S, Rana JS, Schreiner PJ. Marijuana use and risk of prediabetes and diabetes by middle adulthood: the Coronary Artery Risk Development in Young Adults (CARDIA) study. Diabetologia. 2015;58(12):2736–44. doi:10.1007/s00125-015-3740-3. This is the only study of the relationship of marijuana use with diabetes that has a longitudinal component and also the only one with an analysis of marijuana use and prediabetes.

    CAS  Article  PubMed  Google Scholar 

  25. Rajavashisth TB, Shaheen M, Norris KC, Pan D, Sinha SK, Ortega J, et al. Decreased prevalence of diabetes in marijuana users: cross-sectional data from the National Health and Nutrition Examination Survey (NHANES) III. BMJ Open. 2012;2:e000494. doi:10.1136/bmjopen-2011-000494.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Alshaarawy O, Anthony JC. Cannabis smoking and diabetes mellitus: results from meta-analysis with eight independent replication samples. Epidemiology. 2015;26(4):597–600. doi:10.1097/EDE.0000000000000314. This is the most recent published study of the relationship of marijuana use with diabetes and includes a meta-analysis of 8 separate national surveys from 2 different sources.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Willi C, Bodenmann P, Ghali WA, Faris PD, Cornuz J. Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis. JAMA. 2007;298(22):2654–64.

    CAS  Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Stephen Sidney.

Ethics declarations

Conflict of Interest

Stephen Sidney declares that he has no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Lifestyle Management to Reduce Diabetes/Cardiovascular Risk

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Sidney, S. Marijuana Use and Type 2 Diabetes Mellitus: a Review. Curr Diab Rep 16, 117 (2016). https://doi.org/10.1007/s11892-016-0795-6

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11892-016-0795-6

Keywords

  • Marijuana
  • Cannabis
  • Diabetes
  • Epidemiology
  • Endocannabinoid